Literature DB >> 18691046

Trans-resveratrol: a magical elixir of eternal youth?

Francisco Orallo1.   

Abstract

Trans-resveratrol or (E)-resveratrol [3,4',5 trihydroxy-trans-stilbene, t-RESV or (E)-RESV] is a natural component of Vitis vinifera L. (Vitaceae), abundant in the skin of grapes (but not in the flesh) and in the leaf epidermis and present in wines (especially red wines). In in vitro, ex vivo and in vivo experiments, t-RESV exhibits a number of biological activities, including anti inflammatory, antioxidant, platelet antiaggregatory and anticarcinogenic properties, and modulation of lipoprotein metabolism. Some of these activities have been implicated in the cardiovascular protective effects attributed to t-RESV and to red wine. Prior to 2002 there had been no previous studies describing the potential effects of t-RESV on the lifespan extension. However, in the last 5 years, several researchers have reported that t-RESV is a potent activator of sirtuin enzymatic activity, mimics the beneficial effects of caloric restriction (CR), retards the aging process and increases longevity in a number of organisms from different phyla such as yeasts, worms, flies and short-lived fish. In addition, t-RESV seems to be effective in delaying the onset of a variety of age-related diseases in mammals (e.g.: rodents). Therefore, this review will basically focus on the possible role of t-RESV to extend life duration and on some of the mechanisms by which t-RESV may act as an anti-aging agent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691046     DOI: 10.2174/092986708785132951

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  21 in total

Review 1.  Resveratrol and its impact on aging and thyroid function.

Authors:  L H Duntas
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

Review 2.  Promise of resveratrol for easing status epilepticus and epilepsy.

Authors:  Ashok K Shetty
Journal:  Pharmacol Ther       Date:  2011-04-28       Impact factor: 12.310

3.  Resveratrol (trans-3,5,4'-trihydroxystilbene) suppresses EL4 tumor growth by induction of apoptosis involving reciprocal regulation of SIRT1 and NF-κB.

Authors:  Narendra P Singh; Udai P Singh; Venkatesh L Hegde; Hongbing Guan; Lorne Hofseth; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Mol Nutr Food Res       Date:  2011-04-26       Impact factor: 5.914

4.  Aging, Proteotoxicity, Mitochondria, Glycation, NAD and Carnosine: Possible Inter-Relationships and Resolution of the Oxygen Paradox.

Authors:  Alan R Hipkiss
Journal:  Front Aging Neurosci       Date:  2010-03-18       Impact factor: 5.750

5.  Examining the genomic influence of skin antioxidants in vitro.

Authors:  James V Gruber; Robert Holtz
Journal:  Mediators Inflamm       Date:  2010-07-12       Impact factor: 4.711

6.  Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.

Authors:  George R Pettit; Noeleen Melody; Andrew Thornhill; John C Knight; Thomas L Groy; Cherry L Herald
Journal:  J Nat Prod       Date:  2009-09       Impact factor: 4.050

7.  Resveratrol inhibits the proliferation of neural progenitor cells and hippocampal neurogenesis.

Authors:  Hee Ra Park; Kyoung Hye Kong; Byung Pal Yu; Mark P Mattson; Jaewon Lee
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

8.  Resveratrol exerts a biphasic effect on apolipoprotein M.

Authors:  Makoto Kurano; Masumi Hara; Takahiro Nojiri; Hitoshi Ikeda; Kazuhisa Tsukamoto; Yutaka Yatomi
Journal:  Br J Pharmacol       Date:  2015-11-12       Impact factor: 8.739

Review 9.  Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues.

Authors:  Marcella Fulco; Vittorio Sartorelli
Journal:  Cell Cycle       Date:  2008-12-09       Impact factor: 4.534

10.  Protective action of resveratrol in human skin: possible involvement of specific receptor binding sites.

Authors:  Stéphane Bastianetto; Yvan Dumont; Albert Duranton; Freya Vercauteren; Lionel Breton; Rémi Quirion
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.